title: Combination of D-dimer, F1+2 and residual vein obstruction as predictors of VTE recurrence in patients with first VTE episode after OAT withdrawal.
authors.forename: D
authors.initials: D
authors.lastname: Poli
authors.forename: E
authors.initials: E
authors.lastname: Antonucci
authors.forename: G
authors.initials: G
authors.lastname: Ciuti
authors.forename: R
authors.initials: R
authors.lastname: Abbate
authors.forename: D
authors.initials: D
authors.lastname: Prisco
mesh_terms: D000284:Administration, Oral; D000293:Adolescent; D000328:Adult; D000925:Anticoagulants / Q000008:administration & dosage / Q000627:therapeutic use*; D015415:Biomarkers; D002199:Capillary Permeability; D002648:Child; D005260:Female; D005338:Fibrin Fibrinogen Degradation Products / Q000032:analysis*; D005500:Follow-Up Studies; D006801:Humans; D019934:International Normalized Ratio; D008297:Male; D008875:Middle Aged; D010446:Peptide Fragments / Q000032:analysis*; D011237:Predictive Value of Tests; D011446:Prospective Studies; D011516:Prothrombin / Q000032:analysis*; D012008:Recurrence; D012306:Risk; D019851:Thrombophilia / Q000097:blood* / Q000188:drug therapy; D054556:Venous Thromboembolism / Q000097:blood* / Q000453:epidemiology / Q000209:etiology / Q000517:prevention & control; D014859:Warfarin / Q000008:administration & dosage / Q000627:therapeutic use*
chemical_list: D000925:Anticoagulants; D015415:Biomarkers; D005338:Fibrin Fibrinogen Degradation Products; D010446:Peptide Fragments; C036309:fibrin fragment D; C045879:prothrombin fragment 1.2; D014859:Warfarin; D011516:Prothrombin